MyFinsight
Home
Blog
About
Proceeds from issuance of
preferred stock
$1,826K
Proceeds from issuance of
pre-funded warrants
$154K
Total cash provided by
(used in) financing...
$1,862K
(-75.57%↓ Y/Y)
Effects of foreign
exchange rate changes on...
$2K
(-97.85%↓ Y/Y)
Canceled cashflow
$118K
Net decrease in cash
and restricted cash
-$3,474K
(40.05%↑ Y/Y)
Canceled cashflow
$1,864K
Loss on
extinguishment of debt
-$3,504K
(-92.32%↓ Y/Y)
Changes in fair value of
freestanding and hybrid...
-$1,918K
(20.45%↑ Y/Y)
Accrued liabilities
$938K
(-40.67%↓ Y/Y)
Inventory
-$503K
(-234.49%↓ Y/Y)
Depreciation and
amortization expenses
$473K
(-50.57%↓ Y/Y)
Amortization of debt discount
$432K
Stock-based compensation,
vested and released...
$171K
(-70.52%↓ Y/Y)
Amortization of operating
lease - right-of-use...
$69K
(-52.41%↓ Y/Y)
Accounts receivable
-$60K
(83.05%↑ Y/Y)
Share in joint
venture's loss
-$27K
(64.00%↑ Y/Y)
Other receivable
-$24K
(-284.62%↓ Y/Y)
Payment of insurance
financing
$118K
Total cash provided by
(used in) operating...
-$5,338K
(60.49%↑ Y/Y)
Canceled cashflow
$8,119K
Other comprehensive
income (loss)
$1K
Net comprehensive
loss
-$12,801K
(40.30%↑ Y/Y)
Canceled cashflow
$1K
Prepaid expenses and
other current assets
$140K
(-81.94%↓ Y/Y)
Accounts payable
-$138K
(-110.74%↓ Y/Y)
Operating lease liability
-$68K
(50.36%↑ Y/Y)
Deferred revenue
-$42K
(50.59%↑ Y/Y)
Other assets
$11K
(110.38%↑ Y/Y)
Net loss
-$12,802K
Back
Back
Cash Flow
Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc. (JAGX)
source: myfinsight.com